[(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 2-morpholin-4-ylacetate;[(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 3-morpholin-4-ylpropanoate;(1S,2R,5R,7R,8R,9R,11R,13R,14R,15S)-15-[2-[5-[(3,5-dichloro-4-pyridinyl)methylamino]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone

C156H223Cl6N9O42S3 — CID 123965834

IUPAC[(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 2-morpholin-4-ylacetate;[(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 3-morpholin-4-ylpropanoate;(1S,2R,5R,7R,8R,9R,11R,13R,14R,15S)-15-[2-[5-[(3,5-dichloro-4-pyridinyl)methylamino]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone
SMILESCC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2[C@H](SCCOc3cc(NCc4c(Cl)cncc4Cl)ccc3OC)C(=O)O[C@@]21C.CC[C@H]1OC(=O)[C@H](C)[C@@H](OC(=O)CCN2CCOCC2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2[C@H](SCCOc3cc(C(=O)Cc4c(Cl)cncc4Cl)ccc3OC)C(=O)O[C@@]21C.CC[C@H]1OC(=O)[C@H](C)[C@@H](OC(=O)CN2CCOCC2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2[C@H](SCCOc3cc(C(=O)Cc4c(Cl)cncc4Cl)ccc3OC)C(=O)O[C@@]21C
InChIInChI=1S/C55H79Cl2N3O15S.C54H77Cl2N3O15S.C47H67Cl2N3O12S/c1-13-43-55(8)45(49(52(66)75-55)76-23-22-70-42-25-35(14-15-41(42)67-11)40(61)26-36-37(56)28-58-29-38(36)57)32(4)46(63)30(2)27-54(7,68-12)50(74-53-47(64)39(59(9)10)24-31(3)71-53)33(5)48(34(6)51(65)72-43)73-44(62)16-17-60-18-20-69-21-19-60;1-13-42-54(8)44(48(51(65)74-54)75-21-20-69-41-23-34(14-15-40(41)66-11)39(60)24-35-36(55)26-57-27-37(35)56)31(4)45(62)29(2)25-53(7,67-12)49(73-52-46(63)38(58(9)10)22-30(3)70-52)32(5)47(33(6)50(64)71-42)72-43(61)28-59-16-18-68-19-17-59;1-13-36-47(8)37(41(44(57)64-47)65-17-16-60-35-19-29(14-15-34(35)58-11)51-21-30-31(48)22-50-23-32(30)49)26(4)38(53)24(2)20-46(7,59-12)42(27(5)39(54)28(6)43(56)62-36)63-45-40(55)33(52(9)10)18-25(3)61-45/h14-15,25,28-34,39,43,45,47-50,53,64H,13,16-24,26-27H2,1-12H3;14-15,23,26-27,29-33,38,42,44,46-49,52,63H,13,16-22,24-25,28H2,1-12H3;14-15,19,22-28,33,36-37,40-42,45,51,55H,13,16-18,20-21H2,1-12H3/t30-,31-,32-,33+,34-,39+,43-,45+,47-,48+,49+,50-,53+,54-,55-;29-,30-,31-,32+,33-,38+,42-,44+,46-,47+,48+,49-,52+,53-,54-;24-,25-,26-,27+,28-,33+,36-,37+,40-,41+,42-,45+,46-,47-/m111/s1
InChIKeyATGZOUPEDJICLZ-JVFNEILXSA-N
MW3205.44 g/mol
LogP20.50
Rot. Bonds49

About [(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 2-morpholin-4-ylacetate;[(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 3-morpholin-4-ylpropanoate;(1S,2R,5R,7R,8R,9R,11R,13R,14R,15S)-15-[2-[5-[(3,5-dichloro-4-pyridinyl)methylamino]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone

[(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 2-morpholin-4-ylacetate;[(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 3-morpholin-4-ylpropanoate;(1S,2R,5R,7R,8R,9R,11R,13R,14R,15S)-15-[2-[5-[(3,5-dichloro-4-pyridinyl)methylamino]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone (PubChem CID 123965834) has the molecular formula C156H223Cl6N9O42S3 and a molecular weight of 3205.44 g/mol. Its IUPAC name is [(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 2-morpholin-4-ylacetate;[(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 3-morpholin-4-ylpropanoate;(1S,2R,5R,7R,8R,9R,11R,13R,14R,15S)-15-[2-[5-[(3,5-dichloro-4-pyridinyl)methylamino]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone.

Molecular Properties

Compound Name[(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 2-morpholin-4-ylacetate;[(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 3-morpholin-4-ylpropanoate;(1S,2R,5R,7R,8R,9R,11R,13R,14R,15S)-15-[2-[5-[(3,5-dichloro-4-pyridinyl)methylamino]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone
PubChem CID123965834
Molecular FormulaC156H223Cl6N9O42S3
Molecular Weight3205.44 g/mol
Exact Mass3200.29
IUPAC Name[(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 2-morpholin-4-ylacetate;[(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 3-morpholin-4-ylpropanoate;(1S,2R,5R,7R,8R,9R,11R,13R,14R,15S)-15-[2-[5-[(3,5-dichloro-4-pyridinyl)methylamino]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone
SMILESCC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2[C@H](SCCOc3cc(NCc4c(Cl)cncc4Cl)ccc3OC)C(=O)O[C@@]21C.CC[C@H]1OC(=O)[C@H](C)[C@@H](OC(=O)CCN2CCOCC2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2[C@H](SCCOc3cc(C(=O)Cc4c(Cl)cncc4Cl)ccc3OC)C(=O)O[C@@]21C.CC[C@H]1OC(=O)[C@H](C)[C@@H](OC(=O)CN2CCOCC2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2[C@H](SCCOc3cc(C(=O)Cc4c(Cl)cncc4Cl)ccc3OC)C(=O)O[C@@]21C
InChIInChI=1S/C55H79Cl2N3O15S.C54H77Cl2N3O15S.C47H67Cl2N3O12S/c1-13-43-55(8)45(49(52(66)75-55)76-23-22-70-42-25-35(14-15-41(42)67-11)40(61)26-36-37(56)28-58-29-38(36)57)32(4)46(63)30(2)27-54(7,68-12)50(74-53-47(64)39(59(9)10)24-31(3)71-53)33(5)48(34(6)51(65)72-43)73-44(62)16-17-60-18-20-69-21-19-60;1-13-42-54(8)44(48(51(65)74-54)75-21-20-69-41-23-34(14-15-40(41)66-11)39(60)24-35-36(55)26-57-27-37(35)56)31(4)45(62)29(2)25-53(7,67-12)49(73-52-46(63)38(58(9)10)22-30(3)70-52)32(5)47(33(6)50(64)71-42)72-43(61)28-59-16-18-68-19-17-59;1-13-36-47(8)37(41(44(57)64-47)65-17-16-60-35-19-29(14-15-34(35)58-11)51-21-30-31(48)22-50-23-32(30)49)26(4)38(53)24(2)20-46(7,59-12)42(27(5)39(54)28(6)43(56)62-36)63-45-40(55)33(52(9)10)18-25(3)61-45/h14-15,25,28-34,39,43,45,47-50,53,64H,13,16-24,26-27H2,1-12H3;14-15,23,26-27,29-33,38,42,44,46-49,52,63H,13,16-22,24-25,28H2,1-12H3;14-15,19,22-28,33,36-37,40-42,45,51,55H,13,16-18,20-21H2,1-12H3/t30-,31-,32-,33+,34-,39+,43-,45+,47-,48+,49+,50-,53+,54-,55-;29-,30-,31-,32+,33-,38+,42-,44+,46-,47+,48+,49-,52+,53-,54-;24-,25-,26-,27+,28-,33+,36-,37+,40-,41+,42-,45+,46-,47-/m111/s1
InChIKeyATGZOUPEDJICLZ-JVFNEILXSA-N
XLogP20.50
TPSA597.32 Ų
H-Bond Donors4
H-Bond Acceptors54
Rotatable Bonds49
Heavy Atoms216
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003205.44
LogP ≤ 520.50
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1054

Analyze [(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 2-morpholin-4-ylacetate;[(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 3-morpholin-4-ylpropanoate;(1S,2R,5R,7R,8R,9R,11R,13R,14R,15S)-15-[2-[5-[(3,5-dichloro-4-pyridinyl)methylamino]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 2-morpholin-4-ylacetate;[(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 3-morpholin-4-ylpropanoate;(1S,2R,5R,7R,8R,9R,11R,13R,14R,15S)-15-[2-[5-[(3,5-dichloro-4-pyridinyl)methylamino]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone?
The IUPAC name of [(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 2-morpholin-4-ylacetate;[(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 3-morpholin-4-ylpropanoate;(1S,2R,5R,7R,8R,9R,11R,13R,14R,15S)-15-[2-[5-[(3,5-dichloro-4-pyridinyl)methylamino]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone (CID 123965834) is [(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 2-morpholin-4-ylacetate;[(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 3-morpholin-4-ylpropanoate;(1S,2R,5R,7R,8R,9R,11R,13R,14R,15S)-15-[2-[5-[(3,5-dichloro-4-pyridinyl)methylamino]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone.
What is the SMILES notation for [(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 2-morpholin-4-ylacetate;[(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 3-morpholin-4-ylpropanoate;(1S,2R,5R,7R,8R,9R,11R,13R,14R,15S)-15-[2-[5-[(3,5-dichloro-4-pyridinyl)methylamino]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone?
The canonical SMILES for [(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 2-morpholin-4-ylacetate;[(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 3-morpholin-4-ylpropanoate;(1S,2R,5R,7R,8R,9R,11R,13R,14R,15S)-15-[2-[5-[(3,5-dichloro-4-pyridinyl)methylamino]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone is CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2[C@H](SCCOc3cc(NCc4c(Cl)cncc4Cl)ccc3OC)C(=O)O[C@@]21C.CC[C@H]1OC(=O)[C@H](C)[C@@H](OC(=O)CCN2CCOCC2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2[C@H](SCCOc3cc(C(=O)Cc4c(Cl)cncc4Cl)ccc3OC)C(=O)O[C@@]21C.CC[C@H]1OC(=O)[C@H](C)[C@@H](OC(=O)CN2CCOCC2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2[C@H](SCCOc3cc(C(=O)Cc4c(Cl)cncc4Cl)ccc3OC)C(=O)O[C@@]21C.
What is the InChIKey of [(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 2-morpholin-4-ylacetate;[(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 3-morpholin-4-ylpropanoate;(1S,2R,5R,7R,8R,9R,11R,13R,14R,15S)-15-[2-[5-[(3,5-dichloro-4-pyridinyl)methylamino]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone?
The InChIKey is ATGZOUPEDJICLZ-JVFNEILXSA-N. The full InChI is InChI=1S/C55H79Cl2N3O15S.C54H77Cl2N3O15S.C47H67Cl2N3O12S/c1-13-43-55(8)45(49(52(66)75-55)76-23-22-70-42-25-35(14-15-41(42)67-11)40(61)26-36-37(56)28-58-29-38(36)57)32(4)46(63)30(2)27-54(7,68-12)50(74-53-47(64)39(59(9)10)24-31(3)71-53)33(5)48(34(6)51(65)72-43)73-44(62)16-17-60-18-20-69-21-19-60;1-13-42-54(8)44(48(51(65)74-54)75-21-20-69-41-23-34(14-15-40(41)66-11)39(60)24-35-36(55)26-57-27-37(35)56)31(4)45(62)29(2)25-53(7,67-12)49(73-52-46(63)38(58(9)10)22-30(3)70-52)32(5)47(33(6)50(64)71-42)72-43(61)28-59-16-18-68-19-17-59;1-13-36-47(8)37(41(44(57)64-47)65-17-16-60-35-19-29(14-15-34(35)58-11)51-21-30-31(48)22-50-23-32(30)49)26(4)38(53)24(2)20-46(7,59-12)42(27(5)39(54)28(6)43(56)62-36)63-45-40(55)33(52(9)10)18-25(3)61-45/h14-15,25,28-34,39,43,45,47-50,53,64H,13,16-24,26-27H2,1-12H3;14-15,23,26-27,29-33,38,42,44,46-49,52,63H,13,16-22,24-25,28H2,1-12H3;14-15,19,22-28,33,36-37,40-42,45,51,55H,13,16-18,20-21H2,1-12H3/t30-,31-,32-,33+,34-,39+,43-,45+,47-,48+,49+,50-,53+,54-,55-;29-,30-,31-,32+,33-,38+,42-,44+,46-,47+,48+,49-,52+,53-,54-;24-,25-,26-,27+,28-,33+,36-,37+,40-,41+,42-,45+,46-,47-/m111/s1.
What are the key properties of [(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 2-morpholin-4-ylacetate;[(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 3-morpholin-4-ylpropanoate;(1S,2R,5R,7R,8R,9R,11R,13R,14R,15S)-15-[2-[5-[(3,5-dichloro-4-pyridinyl)methylamino]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone?
[(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 2-morpholin-4-ylacetate;[(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 3-morpholin-4-ylpropanoate;(1S,2R,5R,7R,8R,9R,11R,13R,14R,15S)-15-[2-[5-[(3,5-dichloro-4-pyridinyl)methylamino]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone has a molecular weight of 3205.44 g/mol, XLogP of 20.50, 49 rotatable bonds, 4 hydrogen bond donors, and 54 hydrogen bond acceptors.
Where does this data come from?
All data for [(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 2-morpholin-4-ylacetate;[(1S,2R,5R,6S,7S,8R,9R,11R,13R,14R,15S)-15-[2-[5-[2-(3,5-dichloro-4-pyridinyl)acetyl]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-4,12,16-trioxo-3,17-dioxabicyclo[12.3.0]heptadecan-6-yl] 3-morpholin-4-ylpropanoate;(1S,2R,5R,7R,8R,9R,11R,13R,14R,15S)-15-[2-[5-[(3,5-dichloro-4-pyridinyl)methylamino]-2-methoxyphenoxy]ethylsulfanyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone is sourced from PubChem (CID 123965834), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).